Jun Yao Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jun Yao Liu has a total of 343 co-authors. Here are the top co-authors by number of shared publications:
- Babak Baban
European Association for Predictive, Preventive and Personalised Medicine, Brussels, Belgium
5 shared publications - Mahmood S. Mozaffari
Department of Oral Biology and Diagnostic Sciences, The Dental College of Georgia, Augusta University, Augusta, Georgia
5 shared publications - Jack C. Yu
Department of Oral Biology, Georgia Regents University, Building: CL 2140, 1120 15th Street, Augusta, GA 30912 USA
2 shared publications Agnieszka Giemza
VIANESSE AG, Research and Development, Engelberg, Switzerland
1 shared publicationAgnieszka Migasiewicz
1 shared publicationAida I. Isamulaeva
Faculty of Dentistry Medical University “Astrakhan State Medical Academy”, the Ministry of Health of Russia, Russia, Astrakhan, Russia
1 shared publication
Latest Publications
- Open Access
- 9 May 2016
- Published by Springer Nature in EPMA Journal
- Vol. 7 (S1) , 1-42
EPMA-World Congress 2015
A1 Predictive and prognostic biomarker panel for targeted application of radioembolisation improving individual outcomes in hepatocellular carcinoma Jella-
- 9 May 2016
- Published by Springer Nature in EPMA Journal
- Vol. 7 (S1) , 1-42
Open AccessEPMA-World Congress 2015
A1 Predictive and prognostic biomarker panel for targeted application of radioembolisation improving individual outcomes in hepatocellular carcinoma Jella-
- Open Access
- 6 October 2015
- Published by Springer Nature in SpringerPlus
- Vol. 4 (1) , 1-8
Whole body vibration therapy: a novel potential treatment for type 2 diabetes mellitus
There is a worsening epidemic of obesity and diabetes in the world. Life style interventions including dietary changes and increase in exercise can improve glucose metabolism and health in general. However, standard exercise programs are strenuous, time-consuming, and thus have low long-term compliance issues. We tested the feasibility of using high frequency, low amplitude whole body vibration (WBV) therapy to improve glucose metabolism in young type 2 diabetic (T2DM) mice. We also aimed to investigate the postulated anti-inflammatory and cytoprotective properties of WBV. Male db/db and db/m mice were exposed to high frequency, low-amplitude WBV. Outcome parameters comprised of body weight, hemoglobin A1c (HbA1c) level, as well as interleukin (IL)-17 (a marker of helper T cells), forkhead box P3 (Foxp3; a marker of regulatory T cells), and gammaH2AX (an index of DNA injury) expression. Furthermore, a 24 h metabolic cage study was carried out immediately after the WBV protocol and fluid intake, urine excretion and urine osmolality were determined. WBV did not affect body weight but improved HbA1c levels in db/db mice. Vibrated db/db mice demonstrated less fluid intake and urine excretion but better urinary concentrating ability than their non-vibrated controls. Pro-inflammatory changes were significantly reduced, as indicated by reduced IL-17 but increased Foxp3 expression. WBV reduced gammaH2AX in db/db mice suggestive of cytoprotective effect. However, WBV was largely without significant effects on assessed parameters in db/m mice. Collectively, our findings suggest that daily, short duration WBV may improve glycemic control, polydipsia, polyuria, and urine osmolality in T2DM in association with reduced inflammation. Thus, WBV may be a viable adjunctive treatment strategy in T2DM.
- 6 October 2015
- Published by Springer Nature in SpringerPlus
- Vol. 4 (1) , 1-8
Open AccessWhole body vibration therapy: a novel potential treatment for type 2 diabetes mellitus
There is a worsening epidemic of obesity and diabetes in the world. Life style interventions including dietary changes and increase in exercise can improve glucose metabolism and health in general. However, standard exercise programs are strenuous, time-consuming, and thus have low long-term compliance issues. We tested the feasibility of using high frequency, low amplitude whole body vibration (WBV) therapy to improve glucose metabolism in young type 2 diabetic (T2DM) mice. We also aimed to investigate the postulated anti-inflammatory and cytoprotective properties of WBV. Male db/db and db/m mice were exposed to high frequency, low-amplitude WBV. Outcome parameters comprised of body weight, hemoglobin A1c (HbA1c) level, as well as interleukin (IL)-17 (a marker of helper T cells), forkhead box P3 (Foxp3; a marker of regulatory T cells), and gammaH2AX (an index of DNA injury) expression. Furthermore, a 24 h metabolic cage study was carried out immediately after the WBV protocol and fluid intake, urine excretion and urine osmolality were determined. WBV did not affect body weight but improved HbA1c levels in db/db mice. Vibrated db/db mice demonstrated less fluid intake and urine excretion but better urinary concentrating ability than their non-vibrated controls. Pro-inflammatory changes were significantly reduced, as indicated by reduced IL-17 but increased Foxp3 expression. WBV reduced gammaH2AX in db/db mice suggestive of cytoprotective effect. However, WBV was largely without significant effects on assessed parameters in db/m mice. Collectively, our findings suggest that daily, short duration WBV may improve glycemic control, polydipsia, polyuria, and urine osmolality in T2DM in association with reduced inflammation. Thus, WBV may be a viable adjunctive treatment strategy in T2DM.
- Open Access
- 11 February 2014
- Published by Springer Nature in EPMA Journal
- Vol. 5 (S1) , A67
Apoptosis of stem cells likely determines the manifestation of type 2 diabetic nephropathy: predictive and preventive potentials
- 11 February 2014
- Published by Springer Nature in EPMA Journal
- Vol. 5 (S1) , A67
Open AccessApoptosis of stem cells likely determines the manifestation of type 2 diabetic nephropathy: predictive and preventive potentials
- Open Access
- 11 February 2014
- Published by Springer Nature in EPMA Journal
- Vol. 5 (S1) , A115
Programmed death-1in cancer stem cells may serve as a novel immunotherapy marker
- 11 February 2014
- Published by Springer Nature in EPMA Journal
- Vol. 5 (S1) , A115
Open AccessProgrammed death-1in cancer stem cells may serve as a novel immunotherapy marker
- Open Access
- 11 February 2014
- Published by Springer Nature in EPMA Journal
- Vol. 5 (S1) , A110
GADD153 as a novel molecular fingerprint for Sjögren’s syndrome
- 11 February 2014
- Published by Springer Nature in EPMA Journal
- Vol. 5 (S1) , A110
Open AccessGADD153 as a novel molecular fingerprint for Sjögren’s syndrome
- 1 December 2012
- Vol. 25 (6) , 327-31
Use of a new, simple, laboratory method for screening the antimicrobial and antiviral properties of hand sanitizers.
To develop a simple, laboratory method for screening the antimicrobial/antiviral activity of hand sanitizers, to replace the more time consuming use of human volunteers. A Rapid Agar Plate Assay (RAPA) was developed that uses sterile agar plates to simulate skin surfaces. After treating the agar plates with putative hand sanitizers, the plates were inoculated with gram-positive S. aureus or gram-negative E. coli. Untreated agar plates served as controls. After incubation for 48 hours, the bacteria were recovered and stained with fluorescent dyes. The number of live/dead bacteria was quantitated by flow cytometry. For anti-viral activity, mammalian cell lines were grown to confluency and infected with noroviruses (murine norovirus or feline calicivirus), and the number of dead cells was quantitated as the log10 of number of cells killed. A liquid hand soap without any antibacterial activity (LHS) was used as the control. A popular ethanol-based hand sanitizer (GHS) was compared to a new quaternary ammonium-containing bactericidal hand cream (ABC). The liquid soap was not effective against either gram-positive or gram-negative bacteria, or viruses. Both GHS and ABC were very effective against S. aureus, but much less so against E. coli. Both GHS and ABC were even more effective against the two noroviruses that cause gastrointestinal diseases, than they were against gram-positive bacteria. These results support the use of RAPA as an effective laboratory screening test to evaluate the antibacterial/antiviral activity of hand sanitizers or other antimicrobial products.
- 1 December 2012
- Vol. 25 (6) , 327-31
Use of a new, simple, laboratory method for screening the antimicrobial and antiviral properties of hand sanitizers.
To develop a simple, laboratory method for screening the antimicrobial/antiviral activity of hand sanitizers, to replace the more time consuming use of human volunteers. A Rapid Agar Plate Assay (RAPA) was developed that uses sterile agar plates to simulate skin surfaces. After treating the agar plates with putative hand sanitizers, the plates were inoculated with gram-positive S. aureus or gram-negative E. coli. Untreated agar plates served as controls. After incubation for 48 hours, the bacteria were recovered and stained with fluorescent dyes. The number of live/dead bacteria was quantitated by flow cytometry. For anti-viral activity, mammalian cell lines were grown to confluency and infected with noroviruses (murine norovirus or feline calicivirus), and the number of dead cells was quantitated as the log10 of number of cells killed. A liquid hand soap without any antibacterial activity (LHS) was used as the control. A popular ethanol-based hand sanitizer (GHS) was compared to a new quaternary ammonium-containing bactericidal hand cream (ABC). The liquid soap was not effective against either gram-positive or gram-negative bacteria, or viruses. Both GHS and ABC were very effective against S. aureus, but much less so against E. coli. Both GHS and ABC were even more effective against the two noroviruses that cause gastrointestinal diseases, than they were against gram-positive bacteria. These results support the use of RAPA as an effective laboratory screening test to evaluate the antibacterial/antiviral activity of hand sanitizers or other antimicrobial products.